GCI

21st November 2024
07:00

Shield Therapeutics - Business Update

29th October 2024
07:00

Shield Therapeutics - Q3 Trading Update

25th September 2024
06:00

Shield Therapeutics - Results from Phase 3 paediatric study

4th September 2024
06:00

Shield Therapeutics - Interim results

27th August 2024
06:00

Shield Therapeutics - ACCRUFeR® Approved by Health Canada

14th August 2024
06:00

Shield Therapeutics - Notice of interim results

24th July 2024
06:01

Shield Therapeutics - Unaudited Q2 2024 Trading Update

24th July 2024
06:00

Shield Therapeutics - Directorate Change

3rd July 2024
06:00

Shield Therapeutics - $5.7m Milestone Monetization Agreement with AOP

20th June 2024
15:25

Shield Therapeutics - Results of 2024 Annual General Meeting

28th May 2024
06:00

Shield Therapeutics - New Drug Application for Accrufer® in South Korea

10th May 2024
14:30

Shield Therapeutics - Audited results for the year ended 31 Dec 2023

Shield Therapeutics Plc (STX.L) Share Price & News

Bid

-

-

-

Ask

High
-
OPEN
-
VOL
-
MKT CAP
-M

LOW
-
CLOSE
-
SHARES IN ISSUE
782.06M

Watchlist